Mimedx Group Inc (NASDAQ:MDXG) shares traded -3.29% down during most recent session to reach at the closing price of $3.23. The stock exchanged hands 5.32 Million shares versus average trading capacity of 3.09 Million shares, yielding a market cap of $426.07 Million. Wall Street analysts covering the stock are projecting that the stock will reach $18.5 within the next 52-weeks. The mean target projections are based on 2 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Mimedx Group Inc (NASDAQ:MDXG) high price target of $19 and with a conservative view have low price target of $18.
Lake Street “Downgrades” Mimedx Group Inc (NASDAQ:MDXG) in a research note issued to investors on 2/26/18 to Hold.
Additionally on 2/20/18 Needham “Downgrades” Mimedx Group Inc (NASDAQ:MDXG) to Hold and on 5/23/17 First Analysis “Downgrades” the stock to Underweight. Furthermore on 3/03/17 PiperJaffray “Initiates Coverage On” the stock to Overweight at $10.
On the other hand the company has Relative Strength Index (RSI 14) of 26.33 along with Average True Range (ATR 14) of 0.62, Consequently Mimedx Group Inc (NASDAQ:MDXG)’s weekly and monthly volatility is 14.44%, 10.41% respectively. The company’s beta value is at 1.74.
In terms of Buy, Sell or Hold recommendations, Mimedx Group Inc (NASDAQ:MDXG) has analysts’ mean recommendation of 2.5. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Mimedx Group Inc (NASDAQ:MDXG)’s minimum EPS for the current quarter is at $0.1 and can go high up to $0.11. The consensus mean EPS for the current quarter is at $0.11 derived from a total of 3 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.07 earnings per share for the same quarter during last year.
Previously Mimedx Group Inc (NASDAQ:MDXG) reported $0.08 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.08 by $0. The company posted an earnings surprise of 0%.
Mimedx Group Inc (NASDAQ:MDXG)’s revenue estimates for the current quarter are $88.8 Million according to 3 number of analysts, for the current quarter the company has high revenue estimates of $90.91 Million in contradiction of low revenue estimates of $87.5 Million. For the current year the company’s revenue estimates are $322.4 Million compared to low analyst estimates of $321.1 Million and high estimates of $324.5 Million according to 3 number of analysts.
Currently Mimedx Group Inc (NASDAQ:MDXG)’s shares owned by insiders are 5%, whereas shares owned by institutional owners are 77.9%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded -0.01%.
Mimedx Group Inc (NASDAQ:MDXG)’s trailing twelve month revenues are $303.5 Million, whereas its price to sales ratio for the same period is 1.4. Its book value per share for the most recent quarter is $1.33 while its price to book ratio for the same period is 2.43, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock has 5 year expected PEG ratio of 0.71 whereas its trailing twelve month P/E ratio is 10.63.